Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overman

Showing results (71-80 of 265) with videos related to

Pageof 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 15, 2012
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancerRenata Ferrarotto, Karime Machado, Milena P Mak, et al.
Neurology|October 26, 1999
Bilateral thalamic stimulation for the treatment of essential tremorR Pahwa, K L Lyons, S B Wilkinson, et al.
The Oncologist|June 1, 2019
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal CancerMichael A Morse, Michael J Overman, Leighanne Hartman, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapyZ-Q Jiang, G Varadhachary, X Wang, et al.
Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2012
A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after strokeJustine J Overman, Andrew N Clarkson, Ina B Wanner, et al.
Pageof 27

Showing results (71-80 of 265) with videos related to

Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|February 15, 2012
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancerRenata Ferrarotto, Karime Machado, Milena P Mak, et al.
Neurology|October 26, 1999
Bilateral thalamic stimulation for the treatment of essential tremorR Pahwa, K L Lyons, S B Wilkinson, et al.
The Oncologist|June 1, 2019
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal CancerMichael A Morse, Michael J Overman, Leighanne Hartman, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapyZ-Q Jiang, G Varadhachary, X Wang, et al.
Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2012
A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after strokeJustine J Overman, Andrew N Clarkson, Ina B Wanner, et al.
Pageof 27